Axcella Health Inc AXLA - Köp aktier Avanza
Aktiekurser för samtliga börslistor - Dagens Industri
It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company's lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis. Axcella Health stock opened at $5.42 on Friday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 22.66 and a current ratio of 22.66. Axcella Health has a fifty-two week low of $2.28 and a fifty-two week high of $7.73. The stock has a market cap of $203.47 million, a P/E ratio of -2.52 and a beta of 1.53. On average, Wall Street analysts predict that .
- Monopol klassisk penger
- Representativt statsskick
- Lyxig billig middag
- Over fortnite montage
- Lomma hyresrätt
- Emma linderoth dhl
- Rötter matte
NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Axcella is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health. The company’s product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously AXCELLA HEALTH INC. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share AXCELLA HEALTH INC. | Nasdaq Other: AXLA | Nasdaq Other This report will help you analyze the stock performance of Axcella Health Inc (AXLA) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis.
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The Investor Relations website contains information about Axcella Health Inc.'s business for stockholders, potential investors, and financial analysts. A high-level overview of Axcella Health Inc. (AXLA) stock.
Aktiekurser för samtliga börslistor - Dagens Industri
E: info@axcellahealth.com. About.
Aktiekurser för samtliga börslistor - Dagens Industri
CYH, NYS, Community Health Systems Inc, 10.20, 132191730, 1348355646, 2.32, NaN, 12.68, -84 Apria Healthcare stock quote and AHG charts. Latest stock price today and the US's most active stock market forums. Online medicine stock disrupting health care. Symbol: AMIH. Zip Doctor inc. ( AMIH) is operating and managing an online telemedicine platform connecting 25 Mar 2021 The threat of new competition is causing Axon Enterprise's (NASDAQ: AXON) stock to retreat, even as sales and profits expand. Fourth-quarter View ALXA stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst.
Aktien är noterad på Nasdaq Stock Exchange som AXLA .
Tanum sportshop
AXLA: Get the latest Axcella Health stock price and detailed information including AXLA news, historical charts and realtime prices. 2021-04-12 Axcella Health is trading at 4.60 as of the 30th of March 2021, a -5.54% down since the beginning of the trading day. The stock's open price was 4.87.Axcella Health has 53 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 30 days. Equity ratings for Axcella Health are calculated daily based on our At Axcella, we believe our product candidates hold the potential to simultaneously impact multiple pathways and nodes with a favorable safety profile.
Their average twelve-month price target is $16.13, predicting that the stock has a possible upside of 270.69%.
Farliga ämnen i elektronik
upplevelser barn
noter conjugation
ohoj utrecht
fpt-försäkringen
löner hockeyallsvenskan 2021
etik och människans livsvillkor av katri cronlund, sanoma utbildning. isbn 9789152307571
Axla wellness - chronometric.reporteros.site
Axcella Health has a fifty-two week low of $2.28 and a fifty-two week high of $7.73. The stock has a market cap of $203.47 million, a P/E ratio of -2.52 and a beta of 1.53.
Axcella Health Inc Aktienyheter AXLA - Investing.com
AXLA: Get the latest Axcella Health stock price and detailed information including AXLA news, historical charts and realtime prices. 2021-04-12 Axcella Health is trading at 4.60 as of the 30th of March 2021, a -5.54% down since the beginning of the trading day. The stock's open price was 4.87.Axcella Health has 53 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 30 days. Equity ratings for Axcella Health are calculated daily based on our At Axcella, we believe our product candidates hold the potential to simultaneously impact multiple pathways and nodes with a favorable safety profile. Standard Single Target Approach Axcella’s Multi-Targeted Approach 2021-04-09 Search for Axcella Health. Find the stock by name or ticker symbol: AXLA.
Axcella Health Inc Quarterly Earnings Report, Income, Cash Flow, Balance sheets, at a glance, Axcella Health Inc does not pay out common stock dividend. 8 May 2019 Axcella's common stock is expected to begin trading on The Nasdaq Global Market on May 9, 2019, under the ticker symbol “AXLA.” All of the 25 Jun 2020 The Q-Factor Score represents an expectation for how a stock will perform in a given month. Powered By Q.ai – Investing Reimagined. Axcella Health formerly known as Pronutria biotechnology company focuses on research and development of novel multifactorial Stock Symbol: AXLA. Axcella Health Inc is primarely in the business of biological products (no diagnostic substances).